Both in Pharmaceuticals
Lyell Immunopharma vs Contineum Therapeutics
Over the past year LYEL returned −3.3% and CTNM returned −5.8%; their daily moves had a correlation of 0.24.
LYEL −3.3% CTNM −5.8%Growth of $1, one year, split-adjusted
| Metric | LYEL | CTNM |
|---|---|---|
| Price | $15.43 | $9.79 |
| Market cap | $378.1M | $368.3M |
| Today | +43.27% | +1.03% |
| 1 month | +79.2% | −22.6% |
| 6 months | −26.0% | −34.5% |
| Year to date | −49.9% | −14.3% |
| 1 year | −6.8% | −8.1% |
| Revenue growth (YoY) | −50.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −1118875.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 14,004.2× | — |
| Net cash | $204.1M | $236.6M |
| Dividend yield | — | — |
| Volatility (60d) | 101.1% | 117.4% |
| Short % of float | 15.8% | 13.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).